Find a Clinical Trial
Is a clinical trial right for you? Search our database to find studies for which you may be eligible.
A Phase I Open-Label, Multi-Center Study of PSMA Targeted Genetically Modified Chimeric Antigen Receptor T Cells in Patients with Metastatic Castration Resistant Prostate Cancer
High-dose Vitamin D Supplementation for ADT-Induced Bone Loss in Older Prostate Cancer Patients
Study Type: Treatment
Phase: III
NCTID: NCT05838716
Principal Investigator:
Elizabeth Wulff-Burchfield
Phase III Study, CONTACT-02: A Phase III, Randomized, Open-Label, Controlled Study of Cabozantinib XL 184 in Combination with Atezolizumab vs Second Novel Hormonal Therapy NHT in Subjects with Metastatic Castration-Resistant Prostate Cancer
Multiparametric MRI mpMRI for Preoperative Staging and Treatment Planning for Newly-Diagnosed Prostate Cancer
A Multi-Center, Randomized, Assessor-Blind, Controlled Trial Comparing the Occurrence of Major Adverse Cardiovascular Events MACEs in Patients with Prostate Cancer and Cardiovascular Disease Receiving Degarelix GnRH Receptor Antagonist or Leuprolide GnRH Receptor Agonist
A Phase II Multiple-Dose, Multiple-Arm, Parallel Assignment Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of XmAb20717 Alone or in Combination with Chemotherapy or Targeted Therapies in Selected Subjects with Metastatic Castration-Resistant Prostate Cancer
A Phase III, Multi-center, Open-label Study to Test the Diagnostic Performance of Copper Cu 64 PSMA IT PET/CT in Men with Biochemical Recurrence of Prostate Cancer
Effectiveness of the SpaceOAR Vue System in Subjects with Prostate Cancer being Treated with Stereotactic Body Radiotherapy SABRE
Study Type: Prevention
Phase: N/A
NCTID: NCT04905069
Principal Investigator:
Ronald Chen